Kathryn Dahir

1.4k total citations
56 papers, 745 citations indexed

About

Kathryn Dahir is a scholar working on Endocrinology, Diabetes and Metabolism, Rheumatology and Nephrology. According to data from OpenAlex, Kathryn Dahir has authored 56 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Rheumatology and 16 papers in Nephrology. Recurrent topics in Kathryn Dahir's work include Alkaline Phosphatase Research Studies (29 papers), Parathyroid Disorders and Treatments (16 papers) and Heterotopic Ossification and Related Conditions (15 papers). Kathryn Dahir is often cited by papers focused on Alkaline Phosphatase Research Studies (29 papers), Parathyroid Disorders and Treatments (16 papers) and Heterotopic Ossification and Related Conditions (15 papers). Kathryn Dahir collaborates with scholars based in United States, Canada and France. Kathryn Dahir's co-authors include Priya S. Kishnani, Lothar Seefried, Agnès Linglart, Keiichi Ozono, Cheryl R. Greenberg, Wolfgang Högler, Gabriel Ángel Martos‐Moreno, Juan M. Colazo, Anna Petryk and Myrick C. Shinall and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

In The Last Decade

Kathryn Dahir

51 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Dahir United States 17 441 262 193 189 167 56 745
Sasigarn A. Bowden United States 14 247 0.6× 82 0.3× 37 0.2× 74 0.4× 117 0.7× 36 545
Misako Ueda Japan 11 182 0.4× 48 0.2× 138 0.7× 123 0.7× 46 0.3× 15 438
Kurt Sowers United States 6 89 0.2× 78 0.3× 472 2.4× 40 0.2× 141 0.8× 6 681
Lynley Ward Australia 14 451 1.0× 101 0.4× 19 0.1× 134 0.7× 135 0.8× 21 834
Roberto Valenti Italy 9 135 0.3× 56 0.2× 31 0.2× 384 2.0× 207 1.2× 15 611
Diana M. Antoniucci United States 13 65 0.1× 48 0.2× 344 1.8× 140 0.7× 118 0.7× 15 728
Jonaz Ripsweden Sweden 15 79 0.2× 60 0.2× 337 1.7× 68 0.4× 72 0.4× 29 674
Yasunaga Ono Japan 7 75 0.2× 43 0.2× 107 0.6× 81 0.4× 116 0.7× 9 477
Peter Papapetrou Greece 9 158 0.4× 30 0.1× 41 0.2× 197 1.0× 108 0.6× 23 601
F. Zucchi Italy 12 54 0.1× 90 0.3× 34 0.2× 273 1.4× 119 0.7× 21 740

Countries citing papers authored by Kathryn Dahir

Since Specialization
Citations

This map shows the geographic impact of Kathryn Dahir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Dahir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Dahir more than expected).

Fields of papers citing papers by Kathryn Dahir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Dahir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Dahir. The network helps show where Kathryn Dahir may publish in the future.

Co-authorship network of co-authors of Kathryn Dahir

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Dahir. A scholar is included among the top collaborators of Kathryn Dahir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Dahir. Kathryn Dahir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dahir, Kathryn, et al.. (2025). Hypophosphatasia: low penetrance of pathogenic and likely-pathogenic ALPL variants identified through an unselected biorepository. Journal of Bone and Mineral Research. 41(3). 270–281.
2.
Kishnani, Priya S., Lothar Seefried, Kathryn Dahir, et al.. (2025). Disease burden by ALPL variant number in patients with non-life-threatening hypophosphatasia in the Global HPP Registry. Journal of Medical Genetics. 62(4). 249–257. 4 indexed citations
3.
Rehder, Catherine, Gerald Webersinke, Cheryl R. Greenberg, et al.. (2025). Biochemical phenotype of hypophosphatasia in asymptomatic individuals carrying ALPL variants. Journal of Bone and Mineral Research. 41(3). 259–269. 1 indexed citations
4.
Simmons, Jill H., Edna E. Mancilla, Steven Mumm, et al.. (2025). Duplications within exon 1 of TNFRSF11A encoding receptor activator of nuclear factor-kappa B (RANK) are associated with tendon avulsion. Bone. 197. 117486–117486.
5.
Dahir, Kathryn, et al.. (2025). Medical Management of Hypophosphatasia: Review of Data on Asfotase Alfa. Current Osteoporosis Reports. 23(1). 14–14. 2 indexed citations
6.
Kishnani, Priya S., Lothar Seefried, Keiichi Ozono, et al.. (2025). The Global Hypophosphatasia Registry: lessons learned from a decade of real-world data. Orphanet Journal of Rare Diseases. 20(1). 626–626.
7.
Kishnani, Priya S., Lothar Seefried, Kathryn Dahir, et al.. (2024). New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP Registry. American Journal of Medical Genetics Part A. 194(11). e63781–e63781. 7 indexed citations
8.
Glorieux, Francis H., Bente Langdahl, Roland Chapurlat, et al.. (2024). Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study. Journal of Bone and Mineral Research. 39(9). 1215–1228. 9 indexed citations
9.
Dahir, Kathryn, et al.. (2024). A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United States. Journal of Endocrinological Investigation. 47(6). 1487–1497. 3 indexed citations
10.
Charles, Julia F., et al.. (2024). Rare Causes of Musculoskeletal Pain: Thinking beyond Common Rheumatologic Diseases. SHILAP Revista de lepidopterología. 2024(1). 6540026–6540026.
11.
Kishnani, Priya S., Gabriel Ángel Martos‐Moreno, Agnès Linglart, et al.. (2024). Effectiveness of asfotase alfa for treatment of adults with hypophosphatasia: results from a global registry. Orphanet Journal of Rare Diseases. 19(1). 109–109. 16 indexed citations
12.
Keen, Richard, Kathryn Dahir, Jennifer McGinniss, et al.. (2024). Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial. Journal of Bone and Mineral Research. 39(10). 1486–1492. 3 indexed citations
13.
Colazo, Juan M., Jennifer L. Halpern, Herbert S. Schwartz, et al.. (2023). Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: An evaluation of 95 cases over a period of 25 years. Bone Reports. 19. 101715–101715. 2 indexed citations
14.
Rehder, Catherine, Cheryl R. Greenberg, Kathryn Dahir, et al.. (2023). The Global ALPL gene variant classification project: Dedicated to deciphering variants. Bone. 178. 116947–116947. 26 indexed citations
15.
Martos‐Moreno, Gabriel Ángel, Cheryl R. Greenberg, Keiichi Ozono, et al.. (2023). Clinical Profiles of Children with Hypophosphatasia prior to Treatment with Enzyme Replacement Therapy: An Observational Analysis from the Global HPP Registry. Hormone Research in Paediatrics. 97(3). 233–242. 11 indexed citations
16.
Dahir, Kathryn, María Belén Zanchetta, Cemre Robinson, et al.. (2021). Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience. Journal of the Endocrine Society. 5(9). bvab099–bvab099. 36 indexed citations
17.
Koga, Masashi, Yuka Kinoshita, Hajime Katô, et al.. (2021). Massive calcification around large joints in a patient subsequently diagnosed with adult-onset hypophosphatasia. Osteoporosis International. 33(2). 505–509. 5 indexed citations
18.
Sheehan, Jonathan H., John H. Newman, Jens Meiler, et al.. (2020). Phenotypic Profiling in Subjects Heterozygous for 1 of 2 Rare Variants in the Hypophosphatasia Gene (ALPL). Journal of the Endocrine Society. 4(8). bvaa084–bvaa084. 6 indexed citations
19.
Dahir, Kathryn, et al.. (2020). Is the Climb Worth the View? The Savings/Alert Ratio for Reducing Vitamin D Testing. Applied Clinical Informatics. 11(1). 160–165. 5 indexed citations
20.
Li, Howard, Kathryn Dahir, & Lewis S. Blevins. (2003). Treatment of Adult Patients With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency: A Clinical Practice Audit. Endocrine Practice. 9(5). 347–352. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sasigarn A. Bowden Breakdown of academic impact, for papers by Misako Ueda Breakdown of academic impact, for papers by Kurt Sowers Breakdown of academic impact, for papers by Lynley Ward Breakdown of academic impact, for papers by Roberto Valenti Breakdown of academic impact, for papers by Diana M. Antoniucci Breakdown of academic impact, for papers by Jonaz Ripsweden Breakdown of academic impact, for papers by Yasunaga Ono Breakdown of academic impact, for papers by Peter Papapetrou Breakdown of academic impact, for papers by F. Zucchi
Rankless by CCL
2026